A detailed history of Richard Pzena (Pzena Investment Management LLC) transactions in Pfizer Inc stock. As of the latest transaction made, Pzena Investment Management LLC holds 7,281,709 shares of PFE stock, worth $182 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
7,281,709
Previous 7,257,680 0.33%
Holding current value
$182 Million
Previous $203 Million 3.77%
% of portfolio
0.7%
Previous 0.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $665,603 - $754,270
24,029 Added 0.33%
7,281,709 $211 Million
Q2 2024

Aug 02, 2024

SELL
$25.26 - $29.6 $10.4 Million - $12.2 Million
-412,765 Reduced 5.38%
7,257,680 $203 Million
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $128 Million - $147 Million
4,947,000 Added 181.64%
7,670,445 $213 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $112,750 - $146,451
4,315 Added 0.16%
2,723,445 $78.4 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $175,885 - $205,592
-5,481 Reduced 0.2%
2,719,130 $90.2 Million
Q2 2023

Aug 04, 2023

SELL
$36.12 - $41.79 $622,636 - $720,376
-17,238 Reduced 0.63%
2,724,611 $99.9 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $708,389 - $922,219
-17,984 Reduced 0.65%
2,741,849 $112 Million
Q4 2022

Feb 03, 2023

SELL
$41.75 - $54.5 $4.57 Million - $5.97 Million
-109,519 Reduced 3.82%
2,759,833 $141 Million
Q3 2022

Nov 04, 2022

SELL
$43.76 - $53.42 $4.38 Million - $5.35 Million
-100,083 Reduced 3.37%
2,869,352 $126 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $19.9 Million - $23.6 Million
-427,993 Reduced 12.6%
2,969,435 $156 Million
Q1 2022

May 06, 2022

SELL
$45.75 - $56.69 $73 Million - $90.5 Million
-1,595,690 Reduced 31.96%
3,397,428 $176 Million
Q4 2021

Feb 04, 2022

SELL
$41.32 - $61.25 $1.19 Million - $1.76 Million
-28,776 Reduced 0.57%
4,993,118 $295 Million
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $78.6 Million - $101 Million
2,003,764 Added 66.39%
5,021,894 $216 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $4.27 Million - $4.84 Million
118,931 Added 4.1%
3,018,130 $118 Million
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $2.98 Million - $3.36 Million
89,086 Added 3.17%
2,899,199 $105 Million
Q4 2020

Feb 05, 2021

BUY
$33.47 - $42.56 $2.48 Million - $3.16 Million
74,178 Added 2.71%
2,810,113 $103 Million
Q3 2020

Oct 30, 2020

BUY
$31.75 - $37.25 $9.86 Million - $11.6 Million
310,417 Added 12.8%
2,735,935 $100 Million
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $21.8 Million - $26.4 Million
-722,584 Reduced 22.95%
2,425,518 $79.3 Million
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $9,190 - $13,130
-340 Reduced 0.01%
3,148,102 $103 Million
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $10,303 - $11,693
313 Added 0.01%
3,148,442 $123 Million
Q3 2019

Nov 01, 2019

SELL
$32.49 - $42.13 $188,929 - $244,985
-5,815 Reduced 0.18%
3,148,129 $113 Million
Q2 2019

Aug 02, 2019

SELL
$36.98 - $41.52 $1.45 Million - $1.63 Million
-39,262 Reduced 1.23%
3,153,944 $137 Million
Q1 2019

May 03, 2019

SELL
$37.5 - $41.2 $18.9 Million - $20.7 Million
-502,831 Reduced 13.6%
3,193,206 $136 Million
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $28.6 Million - $32.6 Million
-742,393 Reduced 16.73%
3,696,037 $161 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $628,629 - $762,488
-18,237 Reduced 0.41%
4,438,430 $196 Million
Q2 2018

Aug 03, 2018

BUY
$32.98 - $35.16 $2.94 Million - $3.14 Million
89,174 Added 2.04%
4,456,667 $162 Million
Q1 2018

May 04, 2018

BUY
$31.91 - $37.02 $202,628 - $235,077
6,350 Added 0.15%
4,367,493 $155 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $11.7 Million - $12.5 Million
352,869 Added 8.8%
4,361,143 $158 Million
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $124 Million - $137 Million
4,008,274
4,008,274 $143 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track Richard Pzena's Portfolio

Track Richard Pzena Portfolio

Follow Richard Pzena (Pzena Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.